Pharma brands with all the right information are still invisible to AI — and why silence is the bigger risk than inaccuracy.
|Articles|November 6, 2015
Elevating the Patient Voice: Leveraging Patients' Expertise to Advance Drug Development
Author(s)DIA
Advertisement
A report on progress with PDUFA V commitments to hold patient-focused drug development meetings; and on how patient focus is being built into 21st Century Cures legislation and forthcoming PDUFA VI reauthorization.
This article appeared in the August 2015 issue of
Advertisement
Related to this article
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Fayuvi for Pediatric Patients with Sanfilippo Syndrome Type A
2
Understanding the Latest with MFN Pricing and What It Means to Pharma
3
The Battle to Own the GLP-1 Patient Journey
4
Novo Announces Drug Discovery Collaboration with Anthropic
5